Invention Grant
- Patent Title: Treatment for multiple myeloma (MM)
-
Application No.: US15569495Application Date: 2016-05-13
-
Publication No.: US10533057B2Publication Date: 2020-01-14
- Inventor: Stéphane LeClair , Jan Endell , Stefan Härtle
- Applicant: MORPHOSYS AG
- Applicant Address: DE Planegg
- Assignee: MORPHOSYS AG
- Current Assignee: MORPHOSYS AG
- Current Assignee Address: DE Planegg
- Agency: Licata & Tyrrell P.C.
- Priority: EP15167597 20150513
- International Application: PCT/EP2016/060810 WO 20160513
- International Announcement: WO2016/180958 WO 20161117
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/28 ; A61P35/00 ; A61K9/00 ; A61K31/573
Abstract:
The present disclosure relates to the treatment of multiple myeloma. Monoclonal antibody MOR202 is efficacious when administered to patient at certain dosage regimens.
Public/Granted literature
- US20190048091A1 TREATMENT FOR MULTIPLE MYELOMA (MM) Public/Granted day:2019-02-14
Information query
